Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

9.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
9.8K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

3.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.7K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

13.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
13.7K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.7K
Tension Response at Adherens Junctions01:26

Tension Response at Adherens Junctions

3.7K
The adherens junctions that anchor cells together are multi-protein complexes that dynamically adapt to mechanical stimuli such as tensile forces and shear stress. Mechanosensory proteins in these junctions can sense such mechanical stimuli and undergo a shift in their conformation, resulting in an altered function — a process called mechanotransduction.
α-Catenin as a Mechanosensory Protein
The α-catenin of adherens junctions is an allosteric protein with three VH (vinculin...
3.7K
Vascular Spasm01:16

Vascular Spasm

4.1K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stop and Go: Barriers and Facilitators to Care Home Research.

The Journal of frailty & aging·2023
Same author

Enhanced activity of an ADAMTS-13 variant (R568K/F592Y/R660K/Y661F/Y665F) against platelet agglutination in vitro and in a murine model of acute ischemic stroke.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial.

Journal of internal medicine·2017
Same author

Conformational quiescence of ADAMTS-13 prevents proteolytic promiscuity: reply.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Conformational quiescence of ADAMTS-13 prevents proteolytic promiscuity.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores.

Journal of thrombosis and haemostasis : JTH·2016

Related Experiment Video

Updated: Feb 19, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
08:30

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation

Published on: August 14, 2017

11.8K

ADAMTS-13 and von Willebrand factor: a dynamic duo.

K South1, D A Lane1

  • 1Centre for Haematology, Imperial College London, London, UK.

Journal of Thrombosis and Haemostasis : JTH
|November 7, 2017
PubMed
Summary

von Willebrand factor (VWF) undergoes critical conformational changes for hemostasis. ADAMTS-13 regulates VWF and its own activity through VWF interaction, impacting bleeding disorders and thrombosis treatments.

Keywords:
TTPVWFADAMTS-13conformational activationhemostasis

More Related Videos

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
11:42

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Published on: July 10, 2017

12.2K
In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions
10:24

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions

Published on: June 11, 2015

11.3K

Related Experiment Videos

Last Updated: Feb 19, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
08:30

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation

Published on: August 14, 2017

11.8K
Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
11:42

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Published on: July 10, 2017

12.2K
In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions
10:24

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions

Published on: June 11, 2015

11.3K

Area of Science:

  • Biochemistry
  • Hematology
  • Molecular Biology

Background:

  • von Willebrand factor (VWF) is essential for hemostasis, mediating platelet adhesion and acting as a factor VIII carrier.
  • VWF requires conformational changes, including A1 domain transitions and A2 domain unfolding, to capture platelets.
  • ADAMTS-13, a metalloproteinase, regulates VWF size and function.

Purpose of the Study:

  • To review recent findings on VWF and ADAMTS-13 conformational transitions.
  • To elucidate the control mechanisms governing these conformational changes.
  • To highlight the clinical significance in hemostasis, bleeding disorders, and therapeutic applications.

Main Methods:

  • Literature review of recent research on VWF and ADAMTS-13.
  • Analysis of studies detailing conformational changes and their regulation.
  • Synthesis of information on clinical implications and therapeutic potential.

Main Results:

  • VWF undergoes significant conformational changes in its A1 and A2 domains for platelet capture.
  • ADAMTS-13 interacts with VWF, inducing a conformational change that enhances its proteolytic activity.
  • These conformational dynamics are crucial for normal hemostasis and are implicated in bleeding disorders.

Conclusions:

  • Conformational transitions in VWF and ADAMTS-13 are tightly controlled and vital for hemostasis.
  • Understanding these changes is key to addressing bleeding disorders.
  • ADAMTS-13 shows promise as an antithrombotic agent for microvascular thrombosis and cardiovascular disease.